Last updated: February 17, 2024
Sponsor: China National Center for Cardiovascular Diseases
Overall Status: Active - Recruiting
Phase
N/A
Condition
Coronary Artery Disease
Vascular Diseases
Cardiovascular Disease
Treatment
Integrated Assessment of Cervicocerebral Vessels
Clinical Study ID
NCT06275139
2023-GSP-GG-9
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients who require CABG surgery; Age ≥18 years with a history of stroke or transientischemic attack; Combined with typical symptoms of stroke; Previous imaging findingssuggest a high risk of stroke
Exclusion
Exclusion Criteria:
- < 18 years old; > 80 years old; Combined with congenital cerebrovascular malformation;Emergency operation; Reluctant to sign an informed consent form; Reluctant to followup
Study Design
Total Participants: 348
Treatment Group(s): 1
Primary Treatment: Integrated Assessment of Cervicocerebral Vessels
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Fuwai Hospital; National Cardiovascular Center; Peking Union Medical College & Chinese Academy of Medical Sciences
Beijing, Beijing 100037
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.